Drugs / Tacrolimus Modified Release (MR)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00064701 Comparator | Jun 2003 → Mar 2005 | — | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tacrolimus Modified Release (MR) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00064701 ↗ |
| Route | Oral | “given as a single oral dose in the morning” NCT00064701 ↗ |